Health Law Update

Home | Health Law Update

<img class="alignright size-full wp-image-5116" src="https://healthlawupdate.bakerhostetlerblogs.com/wp-content/uploads/sites/19/2019/05/1200x630Washington-DC-iStock_000074771283_Blog-image_lt-blue-e1549910644100.jpg" alt="" width="438" height="230" />Here is this week’s “<a href="https://www.ohioclock.com/2019/05/capitol-hill-healthcare-update-25/">Capitol Hill Healthcare Update</a>,” which is posted on Mondays when Congress is in session

<strong>HOUSE TO VOTE ON BILL COMBINING ACA, DRUG PRICING PROVISIONS</strong>

The House is <a href="https://www.majorityleader.gov/content/weekly-leader-friday-may-10-2019">scheduled to vote</a> on <a href="https://www.govinfo.gov/content/pkg/BILLS-116hr987ih/pdf/BILLS-116hr987ih.pdf">legislation</a> Thursday that would package new funding for state-based marketplaces and enrollment outreach efforts under the Affordable Care Act (ACA), with provisions designed to lower prescription drug prices.

Some of the drug pricing provisions enjoyed bipartisan support when considered earlier this year in the <a href="https://energycommerce.house.gov/newsroom/press-releases/ec-chairman-pallone-on-passage-of-12-bills-to-lower-health-care-and">Energy and Commerce Committee</a> and the <a href="https://judiciary.house.gov/news/press-releases/house-judiciary-unanimously-passes-bipartisan-bills-lower-prescription-drug">Judiciary Committee</a>. But House Republicans aren’t expected to support the overall bill because of the ACA funding and provisions that would roll back the Trump administration’s plan to lower insurance premiums for healthier Americans, which Democrats have derided as “junk” insurance plans.

<strong><a href="https://www.ohioclock.com/2019/05/capitol-hill-healthcare-update-25/">Read more on BakerHostetler's Ohio Clock blog &gt;&gt;</a></strong>